Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Liabilities ₹416 Cr₹407 Cr₹378 Cr₹308 Cr₹184 Cr

What is the latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹416 Cr based on Mar2025 Consolidated results.
Year Total Liabilities
Mar2025₹416 Cr
Mar2024₹407 Cr
Mar2023₹378 Cr
Mar2022₹308 Cr
Mar2017₹184 Cr

How is Total Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Liabilities % Change
Mar2025 ₹416 Cr
2.18
Mar2024 ₹407 Cr
7.69
Mar2023 ₹378 Cr
22.58
Mar2022 ₹308 Cr
67.59
Mar2017 ₹184 Cr -

Compare Total Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,311.3 Cr 7.3% 12.7% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,243.0 Cr -1.4% -7.2% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,179.0 Cr 5.7% 0.3% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,670.0 Cr 1.5% -6.5% 28.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,932.0 Cr 0.7% -7.4% 9.9% Stock Analytics
CIPLA ₹99,417.9 Cr 0.5% -7.1% -14.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

7.3%

12.7%

-17.2%

SENSEX

0.6%

1.5%

6.6%


You may also like the below Video Courses